NEUROPHET, Inc. (KOSDAQ:380550)
4,585.00
-300.00 (-6.14%)
Nov 20, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 55.93 billion as of November 20, 2026. It is the 30,799th most valuable company in the world and the 1,629th biggest in South Korea. Its market cap has decreased by 78.20% in one year.
Market Cap
55.93B
Enterprise Value
17.66B
Revenue
2.59B
Global Rank
Country Rank
#1,629 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 55.93B, a decrease of -75.99%. That is a compound annual growth rate of -65.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 55.93B | -78.40% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.65T |
| Celltrion | 48.66T |
| ALTEOGEN | 12.14T |
| Samsung Epis Holdings | 8.67T |
| Sugentech | 58.94B |
| Yuyu Pharma | 58.34B |
| Access Bio | 58.15B |
| Ray Co., Ltd. | 57.01B |